A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients.

Zhang M, He Y, Sun X, Li Q, Wang W, Zhao A, Di W. · 2014

Read A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients. by Zhang M, He Y, Sun X, Li Q, Wang W, Zhao A, Di W. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3939626.txt.

Description

Meiying Zhang and colleagues examine immune cells inside ovarian tumors in the Journal of Ovarian Research in 2014. Tumor-associated macrophages come in two broad types: M1 cells, which fight cancer, and M2 cells, which help it. The team studied tissue from 112 ovarian cancer patients, split by whether they survived five years, and mapped the macrophages' density, position, and type across the different forms of the disease.

Macrophages crowded most into serous tumors, and their density rose with cancer stage and grade. But the balance shifted the wrong way as disease advanced: the M1-to-M2 ratio fell with stage, and a lower ratio inside tumor nests tracked with more leftover disease after surgery. A high ratio, overall and inside the nests, was the one macrophage measure tied to longer survival in the full statistical analysis.

Catalog record

CREATORZhang M, He Y, Sun X, Li Q, Wang W, Zhao A, Di W.
YEAR2014
COLLECTIONPAPERS
FORMATTXT
FILE SIZE64 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3939626

Browse the full library · About the Tower of Babel